Anthony S. Fauci, MD: From AIDS to Zika, Infectious Diseases are a Perpetual Challenge

Video

Anthony S. Fauci, MD, Director, National Institute of Allergy and Infectious Diseases (NIAID), shared with MD Magazine what the main theme would be in his keynote address at the AAAAI 2017 meeting in Atlanta, GA: emerging and reemerging infections, a perpetual challenge.

Anthony S. Fauci, MD, director, National Institute of Allergy and Infectious Diseases (NIAID), shared a preview of his keynote address at the AAAAI 2017 meeting in Atlanta, Georgia with MD Magazine. His topic: emerging and re-emerging infections, a perpetual challenge. The message is that there have always been new and re-emerging infections. There are several right now., Fauci said. In addition to Zika virus, there was the Ebola outbreak, and in the future there always will be new infectious diseases and old ones that return.

Fauci also spoke about his role in the ongoing government transition in Washington. He said that prior to the swearing in of the various members of the cabinet he was asked to take part in a briefing of the cabinet about what kinds of surprises or threats they may encounter in the first years of the administration - things like terrorist attacks with bombs and bullets, another Hurricane Sandy, cyber attacks, and emerging and re-emerging infections. He noted that he has decades of experience on which to draw, since he became the director of the NIAID 33 years ago in 1984.

"When I came in, Reagan was president and the emerging infection that we hit there was AIDS. And it seems interesting and almost ludicrous that it was from AIDS and Zika, so it's like A-Z infections. And in there with each administration: George H.W. Bush, Bill Clinon, George W Bush, Barack Obama, and President Trump, we have already seen things besides HIV/AIDS like West Nile Virus, pandemic flu, chikungunya, ebola, and now we're just in the middle of, towards the end of, and maybe a resurgence of Zika," Fauci said.

"We are going to see some either new or re-emerging infection in the next year or two or three or four, but if history holds true, it certainly will happen in this administration, so we need to be prepared for it," Fauci said.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Sorana Segal-Maurer, MD, an expert on HIV
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.